Egypt, Israel to amend trade pact

Under the 2004 Qualified Industrial Zone agreement, the U.S. agreed to waive duties on imports from Egypt if they were constructed with at least 11.7% Israeli components.

By AP
October 9, 2007 08:26

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Egypt and Israel have agreed to reduce the percentage of Israeli components that must be included in Egyptian-made products that receive duty-free status when exported to the US, Israel's envoy to Egypt said Monday. Industry, Trade and Labor Minister Eli Yishai and his Egyptian counterpart, Rachid Mohamed Rachid, will sign the amended agreement today, Israeli Ambassador Shalom Cohen told reporters in Cairo following talks at the Egyptian Foreign Ministry. Under the 2004 Qualified Industrial Zone agreement, the U.S. agreed to waive duties on imports from Egypt if they were constructed with at least 11.7 percent Israeli components. Cohen said Monday the percentage would decline to 10.5% under the amended agreement.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS